Design and synthesis of the cartilage protective agent (CPA, Ro32-3555)

被引：39

作者：

Broadhurst, MJ ^{[1
]}

Brown, PA ^{[1
]}

Lawton, G ^{[1
]}

Ballantyne, N ^{[1
]}

Borkakoti, N ^{[1
]}

Bottomley, KMK ^{[1
]}

Cooper, MI ^{[1
]}

Eatherton, AJ ^{[1
]}

Kilford, IR ^{[1
]}

Malsher, PJ ^{[1
]}

Nixon, JS ^{[1
]}

Lewis, EJ ^{[1
]}

Sutton, BM ^{[1
]}

Johnson, WH ^{[1
]}

机构：

[1] ROCHE DISCOVERY WELWYN,WELWYN GARDEN CIT AL7 3AY,HERTS,ENGLAND

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1997年 / 7卷 / 17期

关键词：

D O I：

10.1016/S0960-894X(97)00416-2

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel series of MMP inhibitors has been identified. The compounds are potent selective inhibitors of collagenase with good solubility and oral bioavailability. One compound, designated Ro32-3555, has been selected for development as a cartilage protective agent for use in the treatment of rheumatoid-and osteoarthritis. (C) 1997 Elsevier Science Ltd.

引用

页码：2299 / 2302

页数：4

共 15 条

[11] NIXON JS, 1991, INT J TISSUE REACT, V13, P237
[12] ON SIZE OF ACTIVE SITE IN PROTEASES .I. PAPAIN
SCHECHTER, I
BERGER, A
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1967, 27 (02) : 157 - +
[13] Schwartz M A, 1992, Prog Med Chem, V29, P271, DOI 10.1016/S0079-6468(08)70011-0
[14] RELATIONSHIP BETWEEN STRUCTURE AND BIOAVAILABILITY IN A SERIES OF HYDROXAMATE BASED METALLOPROTEASE INHIBITORS
SINGH, J
CONZENTINO, P
CUNDY, K
GAINOR, JA
GILLIAM, CL
GORDON, TD
JOHNSON, JA
MORGAN, BA
SCHNEIDER, ED
WAHL, RC
WHIPPLE, DA
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (04) : 337 - 342
[15] INTRAARTICULAR INJECTION OF PROPIONIBACTERIUM-ACNES CAUSES AN EROSIVE ARTHRITIS IN RATS
TRIMBLE, BS
EVERS, CJ
BALLARON, SA
YOUNG, JM
[J]. AGENTS AND ACTIONS, 1987, 21 (3-4): : 281 - 283

← 1 2 →